1. Introduction {#sec0005}
===============

Peste des petits ruminants (PPR) is also known as 'goat plague', 'Kata', 'syndrome of stomatitis-pneumoenteritis' or 'ovine rinderpest'. It is an important infectious viral disease of domestic and wild small ruminants that threatens the food security and sustainable livelihood of farmers across Africa, the Middle East and Asia ([@bib0095]). The disease is emerging in new regions of the world and is causing significant economic losses ([@bib0100]). The causal agent is *Peste des petits ruminants virus*, which belongs to the genus *Morbillivirus* of the family Paramyxoviridae*,* Vaccines have been available to control the disease for decades with two attenuated vaccine strains, Nigeria 75/1 and Sungri 96, being regularly employed in endemic areas with great success ([@bib0865]). For serological diagnosis, commercially available diagnostic ELISAs with high specificity and sensitivity that detect antibodies to either the N or the H proteins of the virus, are available to assess seropositivity within a population ([@bib0085]). However, no tools currently exist that enable serological **D**ifferentiation between **I**nfected and **V**accinated **A**nimals (DIVA). To this end, marker vaccines are a potential solution to the DIVA concept that may play an important role in the reduction of the disease in endemic regions and the success of any future eradication campaign.

2. Taxonomy of the causative virus {#sec0010}
==================================

*Peste des petits ruminants virus* belongs to genus *Morbillivirus*, sub-family Paramyxovirinae*,* family Paramyxoviridae*,* and order Mononegavirales, alongside other important viral pathogens, e.g., *Rinderpest virus*, *Measles viru*s, *Canine distemper virus*, *Phocine distemper viru*s and the morbilliviruses of marine mammals, the cetacean morbilliviruses. The characterisation of novel morbilliviruses have recently been described, including *Feline morbillivirus* in cats ([@bib0975]) and numerous morbilli-like viruses in rodents or bats ([@bib0310]). This viral order contains some of the most significant viral pathogens in the medical and veterinary fields ([Table 1](#tbl0005){ref-type="table"}).

The majority of morbillivirus species can be divided into monophyletic lineages or clades following genetic analysis ([Fig. 1](#fig0005){ref-type="fig"}). Due to the historical detection of cetacean morbilliviruses and the paucity of data available, for cetacean morbilliviruses several species were initially proposed, including viruses infecting dolphins (*Dolphin morbillivirus*), those infecting porpoise (*Porpoise morbillivirus*) and those infecting whales (*Pilot Whale Morbillivirus*). However, following further identification and genetic characterisation of these viruses, they were classified as a single monophyletic group, the cetacean morbilliviruses. Most recently, novel cetacean isolates have been described that cluster within the cetacean morbilliviruses, but are genetically divergent to those previously characterised, further extending the diversity of these viruses ([@bib0130], [@bib0925], [@bib0910]).

In general, morbilliviruses are considered restricted in their ability to infect different species. *Measles virus* infections appear to occur exclusively in humans and non-human primates, rinderpest was restricted to members of the Order Artiodactyla and to date cetacean morbilliviruses have only been reported in aquatic mammals. In contrast, *Peste des petits ruminants virus*, whilst initially thought to be restricted to the infection of small ruminants, has recently been determined to be the cause of mass mortalities in camelids ([@bib0800], [@bib0335]) and has been described, on a single occasion, in felids ([@bib0080]), although further corroboration of this report is needed. The seemingly most promiscuous morbillivirus is *Canine distemper virus*. Initially thought restricted to infection of canids, the virus has been described in numerous species, including tigers, lions, hyenas, polar bears and non-human primates ([@bib0190]). *Feline Morbillivirus* was initially reported in domestic cats in Hong Kong as the proposed causative agent of tubulointerstitial nephritis ([@bib0975]). Since this initial report, several other detections have been made in Japan ([@bib0385], [@bib0830]), with some isolates providing evidence of genetic recombination ([@bib0740]).

Morbilliviruses are characterised at the molecular level most extensively through studies with the prototype virus, Measles Virus and to some extent *Canine distemper virus* and *Rinderpest* virus. *Peste des petits ruminants virus* remains largely uncharacterised with respect to virus replication and transcription. However, the viruses are known to be conserved across the genus with different species sharing similar characteristics. The descriptions of *Peste des petits ruminants virus* in this review are generalised for morbilliviruses with the inclusion of specific literature available for *Peste des petits ruminants virus*.

3. Characteristics of the causative virus {#sec0015}
=========================================

3.1. Virion morphology and genome structure {#sec0020}
-------------------------------------------

Structurally, morbilivirus virions are visualised as pleomorphic, enveloped particles as determined using negative-stain electron microscopy. The virus particle size has been determined to be between 400 and 500 nm ([@bib0405]). During virus budding, the viral envelope is derived from infected cell membrane, and is studded with glycoprotein peplomers consisting of the viral fusion (F) and haemagglutinin (H) glycoproteins ([Fig. 2](#fig0010){ref-type="fig"}a). The *Peste des petits ruminants virus* genome consists of a non-segmented, single-stranded, negative-sense RNA molecule encapsidated by nucleoprotein (N) forming a helical nucleocapsid, in combination with the RNA-dependent RNA polymerase (L; large polymerase) and the co-factor phosphoprotein (P; polymerase complex) to form the ribonucleoprotein (RNP) complex. Ribonucleoproteins are located within the virus envelope and appear as helices with a herringbone appearance ([Fig. 2](#fig0010){ref-type="fig"}b). The matrix protein (M) located on the inner surface of the envelope bridges the ribonucleoprotein and cytoplasmic tails of the membrane glycoproteins. Morbillivirus virions have been shown to be polyploid and as such can include more than one independent and functional fully encapsidated genome in the form of ribonucleoproteins ([@bib0770]). This polyploidy is thought to be the basis behind the virions general pleomorphy.

The *Peste des petits ruminants virus* genome is 15,948 nucleotides in length ([@bib0060]) and conforms to the 'rule of six' (multiple of six) as reported for other paramyxoviruses ([@bib0200]), although a single virus with a hexameric nucleotide insertion in an untranslated region has recently been described ([@bib0115]). This strict requirement of the genome length to be divisible by six reflects on the interaction of each nucleoprotein monomer with exactly six nucleotides along the genome or anti-genome RNAs. Furthermore, the genome must be encapsidated by nucleoprotein in its entirety for efficient genome replication and virus propagation ([@bib0065]). The genome organisation and genetic relationship of *Peste des petits ruminants virus* in comparison to other important paramyxoviruses is presented in [Fig. 3](#fig0015){ref-type="fig"}.

As mentioned earlier, the *Peste des petits ruminants virus* genome consists of six transcriptional units located in the order 3′ N, P, M, F, H and L 5′ that encode for six proteins, N, P, M, F, H and L ([@bib0065]). An additional two non-structural proteins, C and V, are generated from the P open reading frame through the utilisation of alternate start codons and RNA editing, respectively. ([@bib0600]) ([Fig. 3](#fig0015){ref-type="fig"}). Transcriptional units are separated from each other by conserved intergenic (IG) trinucleotides. The *Peste des petits ruminants virus* genome 3′ and 5′ termini sequences are complementary and conserved and from studies with other morbilliviruses play an important role as regulatory elements in replication, transcription and packaging of RNA genome during virus propagation ([@bib0090]). The sizes of genes, intergenic regions, promoter lengths, open reading frames and the deduced molecular weights of the mature proteins are detailed in [Table 2](#tbl0010){ref-type="table"}. The virus leader region, including the 3′ untranslated region (UTR) of the N gene, constitutes the genome promoter (GP) and, similarly, the 5′ UTR of L gene with a short trailer sequence form the anti-genome promoter (AGP). The UTR between the M and F gene ORF is unusually long (1080 nucleotides) compared to other UTRs along the virus genome and is highly rich in G and C nucleotides (68--72% GC across the region). Overall, the virus genome is relatively conserved with a maximum divergence of 12% at nucleotide and 8% at amino acid sequence level ([@bib0690]).

3.2. Virus replication cycle {#sec0025}
----------------------------

The replication cycle for different paramyxoviruses is similar and the first step is the attachment of the virus on the cell surface and membrane fusion to release a genome into the cell cytoplasm ([Fig. 4](#fig0020){ref-type="fig"}) ([@bib0650]). The H protein is responsible for the attachment of the virus to the cell surface through recognition of and binding to host cell receptor molecules, e.g., salicylic acid, immune cell marker signalling lymphocyte activation molecule (SLAM)/CD 150 ([@bib0860], [@bib0020]) or the epithelial cell receptor Nectin-4 ([@bib0165]). Attachment of the H protein to receptors activates the fusion activity of the F protein, enabling a fusion of the viral envelope with the host cell membrane and release of the viral genetic material into the cell cytoplasm.

Morbilliviruses replicate solely in the cytoplasm of host cells. The genome of *Peste des petits ruminants virus* is never found as naked RNA and is fully encapsidated by the N protein to form the helical ribonucleoproteins. This ribonucleoprotein complex protects the RNA from host RNAses. The ribonucleoproteins may consist of genome sense (--ve) or antigenome sense (+ve) strands. The ribonucleoprotein complex containing the RNA encapsidated by N, in conjunction with the P and L proteins, make up the minimal replicative unit for these viruses. In the infected cell, a viral genome is released into the cytoplasm and acted upon by viral polymerase complex, which binds to the genome promoter and starts transcribing short leader RNAs. The polymerase works its way across the genome transcribing each gene in turn falling off at each intergenic region. The dissociation of the polymerase at each intergenic region across the genome leads to the build-up of a transcriptional gradient as the polymerase can only commence transcription at the genome promoter ([Fig. 3](#fig0015){ref-type="fig"}). The mRNAs produced are 5′ methylated and 3′ poly-adenylated by the viral polymerase and are translated by host cell machinery. At a certain time point post-infection, the polymerase complex switches its action from the production of mRNA to the production of a full length positive sense RNA ([Fig. 4](#fig0020){ref-type="fig"}). This switch is thought to be linked to the accumulation of viral proteins within the host cell, although the precise mechanism for an alteration in polymerase activity remains unclear. Following the production of a full length antigenome (+ve) RNA, the polymerase now binds to the antigenome RNA at the antigenome promoter (3′) and generates nascent full length negative sense genomes. The synthesis of viral components within the cell eventually leads to viral egress from the host cell. The M protein plays an important role in bringing the nascent RNPs and viral glycoproteins to the host cell membrane which results in the packaging, budding and release of nascent virions.

4. Epidemiological characteristics {#sec0030}
==================================

4.1. Origin and distribution {#sec0035}
----------------------------

The first report of peste des petits ruminants was published in 1942 in Côte d'Ivoire ([@bib0395]) based on observations that the disease in small ruminants was not transmissible to cattle in contact with them. After three decades, the causative agent of the disease was defined as a distinct entity ([@bib0405]). Earlier, reports in 1871 and 1927 in Senegal and French Guinea, respectively, might have described peste des petits ruminants, but the disease was most likely considered to be rinderpest at the time ([@bib0285]). Contrastingly, cases of rinderpest, with an absence of clinical disease in sheep and goats, are well documented in the same regions of Africa ([@bib0815]).

The molecular epidemiology of the virus, based on the sequence comparison of a small region of the F gene (322 nt; \[[@bib0365]\]), the N gene (255 nt; \[[@bib0245]\]) or the H gene (298 nt; \[[@bib0875]\]), has defined the existence of four distinct lineages (I--IV) of the virus ([@bib0890], [@bib0280], [@bib0095], [@bib0525], [@bib0565]). The nomenclature of lineage I and II are slightly different for analyses depending on whether the N or F gene are being considered (lineage II of F gene data is considered to be lineage I based on N gene data and vice-versa). However, recently a comparison has been made between genetic data derived from the F, N and H genes and the partial N gene sequence revealed a greater variability than the F and H genes; therefore, lineage classification according to the N gene is considered the most accurate way to type novel isolates, as this region is more divergent between lineages and between isolates within lineages ([@bib0875]).

Historically, lineages I--III have been found in Africa and numbered according to the apparent spread of virus from West Africa (I and II) to East Africa (III). Lineage IV was mainly restricted to the Middle East and Asia, with few exceptions of lineage III being reported in Yemen and Oman and mixed lineages of lineage III and IV in the United Arab Emirates and Qatar. However, lineage IV has now established its presence all across the PPR endemic areas with frequent outbreaks in Africa by replacing other lineages ([@bib0525], [@bib0565], [@bib0675]). The apparent expansion of Asian lineage IV across Africa is supported by a constant increase in the incidence of disease, suggesting an increase in virulence ([@bib0565]). Virus lineages circulating in Africa ([Table 3](#tbl0015){ref-type="table"}) or in Asia ([Table 4](#tbl0020){ref-type="table"}) are shown in [Fig. 5](#fig0025){ref-type="fig"}.

Most recently, the evolution of the virus and its relationship with *Rinderpest virus* has been suggested using molecular phylogenetic techniques with virus full genome sequence data. Bayesian phylogenetic studies found that *Rinderpest virus* is more closely related to *Measles virus* than to *Peste des petits ruminants virus* ([@bib0750], [@bib0380]). The origin of ancestral *Peste des petits ruminants virus* and its relation to the other morbilliviruses have recently been estimated using Bayesian analysis of the complete virus genome sequences ([@bib0690]). A Bayesian phylogenetic analysis of all four viral lineages mapped the time to most recent common ancestor at the beginning of the 20th century, a few decades before the first recorded description of the virus in 1942. Lineage III *Peste des petits ruminants virus* is proposed to have been the first to have diverged ([Fig. 6](#fig0030){ref-type="fig"}). The estimated probability for the root location of an ancestral virus and individual lineages were determined as being Nigeria for *Peste des petits ruminants virus*, Senegal for lineage I, Nigeria/Ghana for lineage II, Sudan for lineage III and India for lineage IV ([@bib0690]). In recent years, the disease has extended its distribution southwards in Africa, as far as southern Tanzania (2008) and the Democratic Republic of Congo and Angola (2012) ([@bib0095], [@bib0565]). Disease outbreaks have also been reported across North Africa, including Tunisia (2006), Morocco (2008) and Algeria (2011). Alongside this, the European part of Turkey reported 12 confirmed outbreaks of the disease in sheep and goats in 2011--2012 ([@bib0565]). In Asia, the disease has spread to Tibet (2007) and more recently, throughout China (2013--2014) ([@bib0100]) and Kazakhstan ([@bib0505]).

4.2. Host range {#sec0040}
---------------

Sheep and goats are the primary hosts for *Peste des petits ruminants virus* with few reports of disease outbreak in camels ([@bib0800], [@bib0825], [@bib0490], [@bib0530]). Cattle ([@bib0045], [@bib0540], [@bib0870]), buffalo ([@bib0415]) and pigs ([@bib0700]) develop subclinical infection but are not capable of excreting the virus, and thus are not considered to be important in the epidemiology of the virus. Infection of various wildlife species, mainly living under semi-free range conditions, has been reported ([Table 5](#tbl0025){ref-type="table"}), although their exact role in the epidemiology of the disease needs to be studied.

Infected animals can transmit the virus to close in-contact susceptible animals through exhaled aerosol or clinical excretions (lacrimal, nasal, saliva, feces). The virus is temperature sensitive and readily inactivated in a dry environment ([@bib0820]). Infected animals that recover from disease develop a life-long protective immunity and no carrier state has been identified ([@bib0430]). However, virus can circulate in animals with mild disease, leading to disease outbreaks, during which naive susceptible populations are mixed with those infected and displaying a mild form of disease ([@bib0260], [@bib0100]). Other host factors, e.g., age, sex, breed or season, may also play a role in disease development.

5. Disease processes {#sec0045}
====================

5.1. Clinical signs {#sec0050}
-------------------

Although goats and sheep are the primary hosts for the virus, goats seem to be more susceptible to disease than sheep ([@bib0695]), with some breeds of goat considered to be more susceptible than others ([@bib0255]). The incubation period of the disease is typically 4--6 days, although it may range between 3 and 14 days. During the acute stage of disease, animals show pyrexia (up to 41 °C) that may last for 3--5 days and that can be accompanied by depression, anorexia and dryness of the muzzle. Watery nasal and lachrymal discharges gradually become mucopurulent with excessive salivation. Erosive lesions formed in the oral cavity may become necrotic. In severe cases of the disease, these necrotic lesions progress with the appearance of a deposit of fibrin (caseous deposit) on the tongue. In later stages of the disease, animals develop diarrhoea and coughing with labored, abdominal breathing. Finally, the animal may become dyspnoeic, suffering progressive weight loss and emaciation, ultimately leading to death. In some cases, particularly in mild infections, animals may convalesce, returning to a pre-infection health status within 10--15 days of infection. The morbidity rate can reach 100% with a high case fatality rate in the acute form of disease ([@bib0755]). The above described clinical signs and mortality can vary considerably depending on the virulence of the viral strain and the immunological state of the affected animal ([@bib0710]).

5.2. Pathogenesis {#sec0055}
-----------------

Disease progresses with development of lacrimal, nasal and mucosal discharges and viral material can be detected in such excretions as early as 4 days after infection. Viral antigen has also been observed by histochemical staining in the lymphoid organs, the respiratory and the gastrointestinal tract ([@bib0510], [@bib0755]).

The pathogenesis of peste des petits ruminants has long been assumed to mirror that of rinderpest in cattle ([@bib0965], [@bib0180]). Pathogenesis studies in peste des petits ruminants have mainly been performed through experimental infection with a virulent form of the virus to develop a reliable and reproducible model ([@bib0195], [@bib0330], [@bib0435], [@bib0755], [@bib0125], [@bib0935]). Histological assessment during early infection showed an immune cell proliferation driven by the spread of the virus, similar to that caused by other morbilliviruses ([@bib0755]). The initial site for virus replication is observed within the tonsillar tissue and lymph nodes draining the site of inoculation. It has been proposed that the virus infected immune cells within the respiratory mucosa would migrate to the local lymphoid tissue, where primary virus amplification would occur, with the virus then entering the general circulation. Clinical signs usually develop 3 to 4 days later with established pyrexia and anorexia. Leucopoenia is observed from the fourth day post-infection with considerable reduction of CD4^+^ T cells ([@bib0125], [@bib0445]). The viral antigens have also been observed by immunohistochemical staining in the lymphoid organs ([Fig. 7](#fig0035){ref-type="fig"}a and b), the facial epithelia ([Fig. 7](#fig0035){ref-type="fig"}c and d) and the gastrointestinal tract ([Fig. 7](#fig0035){ref-type="fig"}e and f) ([@bib0510], [@bib0755]). Histopathological assessment of infected tissues revealed a large number of syncytia within the lymphoid tissue from days 5--7 post infection. In the later stage of infection erosive lesions are formed in the oral cavity that also become necrotic. The severity of clinical signs generally peaks between 6 and 8 days post infection and can continue for up to 14 days leading to death or recovery from infection. Despite the segregation of isolates of *Peste des petits ruminants virus* into lineages, the early stages of pathogenesis in goats infected with virulent strains of the virus had no lineage specific difference in the pathogenicity of the virus ([@bib0120]).

5.3. Immunosuppression {#sec0060}
----------------------

*Peste des petits ruminants virus* is highly lymphotropic and infection often leads to a profound immunosuppression that causes leucopoenia and reduced antibody responses ([@bib0755], [@bib0785]). Immunosupression by *Peste des petits ruminants virus* has been observed in both vaccinated and infected animals ([@bib0785]). Virulent strains of the virus cause marked immunosuppression, whereas vaccination only induces a transient leucopoenia with no significant effects on the immune response ([@bib0785]). Leucopoenia is observed generally from the fourth day post-infection and may revert depending on progression of disease ([@bib0755], [@bib0125], [@bib0445]). Blood from *Peste des petits ruminants virus* infected goats was tested for specific immune cell sub populations and it has been shown that no change in the proportion of WC1^+^ *γ*/*δ* T-cells and CD14^+^ monocyte/macrophage cells occurs. However, CD4^+^ cells were found to decrease in number from day 4 post-infection and, surprisingly, the proportion of CD8^+^ cells, although unchanged initially, increased by 7 days post-infection ([@bib0445]).

5.4. Immunological features {#sec0065}
---------------------------

Maternal antibodies against the virus can be detected in young animals and remain able to neutralise virus for three to four months enabling a level of protection in newborn animals ([@bib0550]). Therefore, vaccination of new born animals is not necessary until that age ([@bib0170]). Cellular and humoral immune responses are induced upon infection or vaccination, a feature of the live attenuated vaccines available for the virus. An inflammatory response in goats infected with different strains of the virus was observed with the enhanced expression of cytokines ([@bib0055], [@bib0125]). Morbillivirus non-structural proteins have been shown to play a role in the blocking of type I and type II interferon action ([@bib0720], [@bib0360], [@bib0230]). Cell-mediated and humoral immune responses against the virus are mainly directed against the H, F and N proteins ([@bib0900]). However, immunisation with viral glycoproteins (H and/or F) induces protective humoral immunity, whilst immunisation with the N protein does not ([@bib0900], [@bib0305]). Both cytotoxic B cell and T cell epitopes have been mapped to regions on the N protein ([@bib0635], [@bib0235]) and further a B cell epitope located on the C-terminus of the N protein was demonstrated ([@bib0275]). B cell epitopes have also been mapped to the H protein of the virus ([@bib0790]). The CD8^+^ T cells, but not CD4^+^ cells have been demonstrated to be primed following the experimental challenge of animals vaccinated with a subunit vaccine expressing the virus H protein with a virulent virus ([@bib0445]).

6. Disease diagnosis {#sec0070}
====================

Peste des petits ruminants can be confused with other diseases including rinderpest, bluetongue and contagious caprine pleuropneumonia, due to the similarity of these diseases in clinical signs. Diagnosis of the disease may also be complicated, as the result of secondary bacterial infections specifically caused by *Mannheimia haemolytica*. Therefore, in addition to clinical observations, a differential diagnosis must be confirmed by laboratory diagnostic techniques.

The laboratory tests currently available for diagnosis of the disease can be grouped into three categories: (i) those detecting virus or viral antigen (e.g., virus isolation, antigen capture ELISA, lateral flow devices), (ii) those detecting genetic material from the virus (e.g., RT-PCR, real-time PCR, LAMP PCR) and (iii) those detecting antibodies against the virus (e.g., virus neutralisation test, competitive ELISA, indirect ELISAs). The available laboratory test methods for diagnosis of the disease are summarised in [Table 6](#tbl0030){ref-type="table"}. However, the efficiency of laboratory diagnosis can be greatly influenced by the integrity of the sample received, often affected by the conditions of its by collection and transportation.

Virus neutralisation is considered to be the 'gold standard' test for diagnosis of the disease, although it is a time-consuming method that requires tissue culture facilities. A commercially available competitive ELISA based on either H or N protein is used for the detection of antibodies and RT-PCR including real-time RT-PCR are commonly employed to detect nucleic acid. Finally, an immunochromatographic lateral flow device has been developed as a pen-side test using a monoclonal antibody, specific to the virus H protein ([@bib0185]). This test has recently been validated under field conditions for diagnosis as early as 4 days post-infection, before onset of severe clinical signs ([@bib0125]).

7. Control {#sec0075}
==========

Preventive measures employed in disease free areas include strict restrictions on the importation of animals from disease infected regions. Disease can be efficiently controlled by isolation and slaughtering of infected animals, as well as disinfection of environmental materials and the restriction of animal movements. Immunisation can be performed with commercially available attenuated vaccines that elicit a protective immunity that has been shown to be effective for at least three years post-vaccination ([@bib0305], [@bib0865]). Current vaccination schedules require the immunisation of susceptible animals at least every three years ([@bib0305], [@bib0855]). Vaccination in animals aged 4--6-months is recommended ([@bib0075]). This is an important area in the control programmes of the disease, as introduction of unvaccinated animals into a potentially susceptible population can lead to introduction of the virus into a farm and can cause a fresh outbreak of disease. Currently available vaccines require maintenance of the cold chain to ensure maintenance of maximal virus titre for inoculation and the required serological response to vaccination.

7.1. Attenuated vaccines {#sec0080}
------------------------

Tissue culture rinderpest vaccine (TCRV) used as a heterologous vaccine against peste des petits ruminants was found to be effective, due to the antigenic relatedness between these two ruminant morbilliviruses ([@bib0625]). However, use of this vaccine was prohibited in 1996, due to the lack of DIVA following vaccination and the need for extensive serological monitoring during the final stages of the rinderpest eradication campaign.

In an initial attempt to generate a homologous vaccine, *Peste des petits ruminants virus* was grown on primary cell line of sheep liver cells ([@bib0410]), but after 65 serial passages in primary cell culture, the virus was not sufficiently attenuated ([@bib0150]). Later, [@bib0290] successfully generated an attenuated *Peste des petits ruminants virus* strain, the Nigeria 75/1 strain, by serial passage in Vero cells of a virulent strain. Following 63 passages the virus was deemed suitably attenuated following extensive in vivo studies ([@bib0290], [@bib0025]). Similarly, at least three more vaccine strains, specifically Sungri 96, Arasur 87 and Coimbatore 97, have been developed for use as vaccines following 75 serial passages in Vero cells ([@bib0895]). Currently, Nigeria 75/1 (lineage II) and Sungri 96 (lineage IV) are widely used for vaccination, whereas Arasur 87 has a more limited use within India ([Table 7](#tbl0035){ref-type="table"}). These attenuated vaccines are now available in freeze-dried form and include various chemical stabilisers to reduce the thermolability of the virus and reduce the need for the cold chain ([@bib0625], [@bib0980], [@bib0865]).

7.2. Recombinant subunit vaccines {#sec0085}
---------------------------------

Subunit vaccines for morbilliviruses have been developed for several species. Initial work carried out with *Capripox virus* strains expressing F and H proteins of *Rinderpest virus* were shown to protect goats against *Peste des petits ruminants virus* ([@bib0810]). *Capripox virus* strains expressing the homologous *Peste des petits ruminants virus* H ([@bib0300]) or F ([@bib0155]) proteins have also been shown to protect goats or sheep against infection by *Peste des petits ruminants virus* ([@bib0225]). Concerns regarding efficacy of recombinant bivalent *Capripox virus* and *Peste des petits ruminants virus* vaccine (F and H proteins) in sheep or goats with pre-existing immunity against either of the viruses have been addressed recently ([@bib0205]). Animals with pre-existing immunity for either virus, achieved by immunising animals with a single-type vaccine, were inoculated with the bivalent vaccine and after four weeks were challenged with a virulent *Capripox virus* strain followed by a virulent *Peste des petits ruminants virus* strains after another three weeks. In all cases, complete protection against *Capripox virus* was evident; however, partial protection against *Peste des petits ruminants virus* was detected in animals previously immunised against *Capripox virus*. This indicated a limited replication of the *Capripox*-PPRV F and H bivalent vaccine in the presence of pre-existing antibodies against the virus, which led to a poor expression of the *Peste des petits ruminants virus* F and H proteins and, therefore, reduced the level of antibody response against the latter virus.

The vaccinia virus vector (Modified vaccinia Ankara) expressing *Peste des petits ruminants virus* F and H proteins was shown to protect goats against the disease after the administration of two doses of the vaccine ([@bib0210]), which might decrease its utility as a vaccine candidate. Goats immunised with a vaccine containing recombinant fowl pox virus expressing the H or F proteins of *Peste des petits ruminants virus* had a poor antibody response to the heterologous proteins ([@bib0445]). Recombinant adenovirus vectors expressing glycoproteins of the virus have also been developed ([@bib0765], [@bib0960], [@bib0445], [@bib0805]). The recombinant replication-defective *Human adenovirus* serotype 5 incorporating H or F proteins of *Peste des petits ruminants virus* was shown to induce humoral and cell mediated immunity and protected goats ([@bib0445]) or sheep ([@bib0805]) against challenge with virulent strains of the virus. These vaccines need to be tested further in large scale studies to assess their potency and, more importantly, the duration of immunity in comparison to the conventional live attenuated vaccines, as vaccinated animals are exposed to only one or two proteins of the virus.

Subunit vaccines have also been developed based on *Baculovirus* expression systems expressing the H ([@bib0900]) or F proteins ([@bib0775]) or from the H protein expressed alone in transgenic peanut plants ([@bib0495]). However, these need to be evaluated further for safety and efficacy. Similarly, such assessments are required for DNA vaccines ([@bib0990]) and for virus-like particle based vaccines ([@bib0570]).

7.3. Improvement of existing attenuated vaccines {#sec0090}
------------------------------------------------

Many small ruminant diseases, e.g., goat pox, sheep pox, bluetongue, Rift valley fever, contagious ecthyma, border disease, overlap geographically with peste des petits ruminants and are of economic significance to small ruminant agriculture ([@bib0095], [@bib0850], [@bib0640], [@bib0725], [@bib0620], [@bib0930]). A vaccination programme with increased valency that is able to generate neutralising responses to several disease following a single administration would improve the efficiency of control programmes and reduce costs associated with such a programme. Live bivalent vaccines against goat pox and peste des petits ruminants ([@bib0785], [@bib0460]) or against sheep pox and peste des petits ruminants ([@bib0220]) produced by combining the two antigens during the manufacturing process gave promising results, but require further standardisation and validation.

The need for the further development of vaccines against peste des petits ruminants revolves around three approaches: (i) the development of thermostable vaccine preparations to overcome the costly requirement of cold chain maintenance, (ii) the fulfilment of DIVA principles to enable effective post vaccination seromonitoring and (iii) the production of multivalent vaccines that could induce neutralising responses against several diseases alongside peste des petits ruminants. Whilst only thermostable preparations are primarily required to control the disease, vaccines that could fulfil the other two approaches would significantly reduce costs associated with vaccination, which is a significant issue in regions where the disease is endemic.

Reverse genetics techniques are being investigated to address the DIVA issue in the preparation of relevant vaccines. Reverse genetics provides a means to manipulate RNA virus genomes through DNA copies (cDNA) of the RNA genome. The new genome cDNA can then be manipulated to obtain the modified form of the virus. Use of reverse genetics techniques to negatively or positively tag vaccines ([@bib0465], [@bib0665]), to modify specific epitopes ([@bib0680]) or to insert heterologous epitopes or immunogenic antigens ([@bib0265], [@bib0940], [@bib0945], [@bib0605], [@bib0730], [@bib0735], [@bib0920], [@bib0390], [@bib0575], [@bib0985]) may lead to the development of novel vaccine preparations that fulfil the requirements described above. Recently, positively or negatively marked vaccines ([Fig. 8](#fig0040){ref-type="fig"}) have been developed against peste des petits ruminants ([@bib0680]). In a negatively marked vaccine, the epitope binding site of the C77 monoclonal antibody, the monoclonal antibody used to compete against antibodies in test sera in the competitive H ELISA, was removed by epitope deletion. This vaccine was been taken forward for in vivo assessment and was shown to be safe with a potency similar to the existing Nigeria 75/1 ([@bib0680]). However, although the C77 mAb was unable to bind to the mutated form of H protein in *in vitro* tests, the mutation was not sufficient to enable DIVA under field conditions, hence further alterations to the proposed epitope within H are being investigated.

8. Concluding remarks {#sec0095}
=====================

Peste des petits ruminants affects some of the poorest farming communities on the planet and presents a significant barrier to development and sustainability of small ruminant farming. The successful eradication of rinderpest has led the attention of the scientific community to peste des petits ruminants as a further potential target for global eradication. In a recent meeting, the World Organisation for Animal Health and the Food and Agriculture Organisation have proposed a control programme for the disease with the target year for eradication being 2030 ([@bib0350]). However, the scientific and economic infrastructures present in areas where the disease is endemic, are largely insufficient to mount a viable eradication campaign without international aid. The recent emergence of the disease across China has highlighted the ability of the virus to spread rapidly across vast areas causing significant economic losses ([@bib0100]).

The vaccines currently available to protect small ruminants against the virus are sufficient to enable an eradication campaign, although there is little doubt that refinements to vaccines would reduce the costs associated with control, making eradication in areas with limited resources more readily achievable. Recent advances in the generation of recombinant versions of the virus will serve as suitable starting points for development of novel vaccine formulations ([@bib0465], [@bib0680]). The current understanding of disease pathogenesis and mechanisms of virulence require further expansion that will have ramifications on the knowledge of *Peste des petits ruminants virus* and related viruses of both veterinary and medical importance. Assessment of genetic data is starting to unravel elements of the evolutionary biology behind *Peste des petits ruminants virus* and its relationship with other morbilliviruses ([@bib0690]). The detection and genetic characterisation of novel morbilliviruses from different species may indicate further approaches for the control and eradication of these important viral pathogens.
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![Un-rooted neighbour-joining tree showing the relationships between different morbiliviruses. The phylogenetic tree was constructed using partial N gene sequences of 230 nucleotides (accession nos. [NC_006383](ncbi-n:NC_006383){#intr0005}, *Peste des petits ruminants virus*; [NC_001498](ncbi-n:NC_001498){#intr0010}, *Measles virus*; [AB547189](ncbi-n:AB547189){#intr0015}, *Rinderpest viru*s; [NC_001921](ncbi-n:NC_001921){#intr0020}, *Canine distemper virus*; [KC802221](ncbi-n:KC802221){#intr0025}, *Phocine distemper virus*; [JQ411016](ncbi-n:JQ411016){#intr0030}, *Feline morbillivirus*; [AY949833](ncbi-n:AY949833){#intr0035}, *Porpoise morbillivirus*; [NC_005283](ncbi-n:NC_005283){#intr0040}, *Dolphin morbillivirus*; [AF200818](ncbi-n:AF200818){#intr0045}, *Pilot whale morbillivirus*) with 1000 bootstrap replicates and Kimura 2-parameter model in MEGA 5.2. The scale bar indicates nucleotide substitutions per site.](gr1){#fig0005}

![(a) Schematic diagram of *Peste des petits ruminants* virion structure (adapted from [@bib0095]). The PPRV glycoproteins (F and H) are embedded within the viral envelope. The M protein lines the inner surface of virus envelope. The ribonucleoprotein complex is composed of N, P and L proteins in association with the RNA genome. (b) Electron micrograph of peste des petits ruminants nuclocapsid in the cytoplasm of an infected cell. The viral RNA, completely encapsidated in the viral N protein has a herring-bone like appearance (arrow).](gr2){#fig0010}

![Schematic representation of *Peste des petits ruminants virus* genome organisation. The PPRV genome is a non-segmented, single-stranded negative sense RNA molecule. The genome consists of six transcriptional units (encoding the nucleoprotein \[N\], phosphoprotein \[P\], matrix protein \[M\], fusion protein \[F\], haemagglutinin protein \[H\] and the large/polymerase \[L\] protein) that are flanked by a 3′ genome promoter (GP) and a 5′ anti-genome promoter (AGP) on the negative sense genome RNA. The P gene encodes for two additional non-structural proteins, namely C and V. The V protein is produced due to co-transcriptional P mRNA editing by insertion of non-template G residues at an editing site. The C protein is produced from an alternative reading frame downstream of the P initiation codon. Expression of C occurs following leaky scanning by the polymerase that reads through the first ATG and initiates at the second ATG.](gr3){#fig0015}

![A schematic replication of life cycle of a morbillivirus (adapted from [@bib0650]). The first step in virus infection is the attachment of a virion to a host cell surface receptor which leads to the fusion of viral and cellular membrane. The negative sense RNA genome is released into the cell cytoplasm and transcription initiates to produce viral gene transcripts (mRNAs), which are translated using the host cell transcriptional machinery. Later, following the production of the necessary viral proteins, a switch to a replicative mode occurs that results in the production of a positive sense (+) viral complementary RNA (vcRNA +ve), a replicative intermediate which acts as a template for the generation of progeny negative sense genome RNA. The encapsidated genomes interact with the M protein and the viral glycoproteins, leading to budding of new virions at the host cell plasma membrane. ER: endoplasmic reticulum.](gr4){#fig0020}

![Global spread of *Peste des petits ruminants virus* from its first detection in 1942--2014, including lineage distribution (a: adopted from Food and Agriculture Organisation ([@bib0340]), b: recent circulations of *Peste des petits ruminants virus* in Africa, drawn by using smart draw software).](gr5){#fig0025}

![Time-scaled Bayesian MCC phylogeny tree based on *Peste des petits ruminants virus* complete genome sequences; the tree was constructed using the UCED model and exponential tree prior (branch tips correspond to the date of collection, branch lengths reflect elapsed time---tree nodes are annotated with posterior probability values, estimated median dates of TMRCA and the corresponding 95% HPD interval values of TMRCA indicated as grey bars; the horizontal axis indicates time in years).](gr6){#fig0030}

![Immunohistochemical staining of *Peste des petits ruminants virus* antigen in experimentally infected goats. (a) Predominately peripheral paracortical immunolabelling of syncytia within the LPSLN (7 days post-infection); dendritic-type cells present and positive for virus antigen (arrow) with an infected lymphocyte also present (open arrow). (b) Advanced epithelial infection of the pharyngeal tonsil (7 days post-infection) with syncytia formation. (c) Conjunctival mucosal epithelium (9 days post-infection); evidence of advanced epithelial and proprial infection involving a mixed population of inflammatory and epithelial cells around an exocrine gland (arrows); immunolabelling within the proprial lymphoid follicle circumscribed by this gland (open arrow). (d) Labial mucosal epithelium (9 days post-infection) with a large epithelial syncytium (arrow) seen in the lower stratum spinosum layer. (e) Severe abomasal infection (9 days post-infection) of crypt epithelial cells (arrows). (f) Marked viral infection of both glandular epithelial cells and the immune/inflammatory cells present within the caecum (7 days post-infection). Scale bars represent 100 μm. Adapted from [@bib0755].](gr7){#fig0035}

![Expression of *Peste des petits ruminants virus* (PPRV) N and H proteins and/or GFP with C77 mAb binding activity in the virus recombinants (positive and negative marker vaccine strains) and parental virus infected cells; VDS cells were infected with viruses at an MOI of 0.01 and fixed 24 h post-infection using 4% paraformaldehyde; cells were stained separately with primary antibodies of mouse anti PPRV H (C77) and mouse anti PPRV N (C11) followed by secondary antibody Alexa Fluor 488 goat anti-mouse (red); cell nuclei were stained with DAPI (blue) and GFP autoflorescence (green); expression pattern of the virus N and H proteins were comparable between the recombinant and parental virus. The anti-PPRV H-mAb could not detect mutated H-protein in rPPRV-C77 infected cells. Autoflorescence of GFP was observed in the rescued rPPRV + GFP (an image with the autoflorescence to show GFP was not taken alongside N antibody staining). Adapted from [@bib0680]. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.).](gr8){#fig0040}

###### 

Classification of viruses within the order Mononegavirales.

  Order             Family            Subfamily         Genus
  ----------------- ----------------- ----------------- ---------------------
  Mononegavirales   Bornaviridae                        *Bornavirus*
                    Filoviridae                         *Cuevavirus*
                                                        *Ebolavirus*
                                                        *Marburgvirus*
                    Nyamiviridae                        *Nyavirus*
                    Rhabdoviridae                       *Cytorhabdovirus*
                                                        *Ephemerovirus*
                                                        *Lyssavirus*
                                                        *Novirhabdovirus*
                                                        *Nucleorhabdovirus*
                                                        *Perhabdovirus*
                                                        *Sigmavirus*
                                                        *Sprivivirus*
                                                        *Tibrovirus*
                                                        *Tupavirus*
                                                        *Vesiculovirus*
                    Paramyxoviridae   Pneumovirinae     *Metapneumovirus*
                                                        *Pneumovirus*
                                      Paramyxovirinae   *Aquaparamyxovirus*
                                                        *Avulavirus*
                                                        *Ferlavirus*
                                                        *Henipavirus*
                                                        *Respirovirus*
                                                        *Rubulavirus*
                                                        *Morbillivirus*

###### 

Genome organisation of the *Peste des petits ruminants virus*.

  Sequence components   Position on genome   Total length   5′UTR   ORF    3′UTR   Intergenic region, nt   Protein size, aa   Deduced molecular weight (KDa)
  --------------------- -------------------- -------------- ------- ------ ------- ----------------------- ------------------ --------------------------------
  Leader                1--52                52             NA      NA     NA      (CTT)                   NA                 NA
  N                     55--1744             1689           52      1578   59      CTT                     525                58
  P                     1748--3402           1655           59      1530   66      CTT                     509                55
  V (P)                 1748--3402           1656           59      897    700     CTT                     298                31
  C (P)                 1748--3402           1655           81      534    1040    CTT                     177                20
  M                     3406--4888           1484           32      1008   444     CTT                     335                38
  F                     4892--7302           2410           633     1641   136     CTT                     546                59
  H                     7306--9262           1957           20      1830   107     CTT                     609                69
  L                     9266--15908          6643           22      6552   69      (CTA)                   2183               247
  Trailer               15912--15948         37             NA      NA     NA      NA                      NA                 NA

N: nucleoprotein, P: phosphoprotein, M: matrix, F: fusion, H: haemagglutinin, L: large polymerase, UTR: untranslated region, ORF: open reading frame. NA: not applicable.

###### 

Lineages of *Peste des petits ruminants virus* circulating in different countries of Africa, based on partial N/F gene sequence analysis.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country                            Year of first report   Lineage[a](#tblfn0005){ref-type="table-fn"}   Year of confirmation\            NCBI submission   References
                                                                                                          of outbreak through sequencing                     
  ---------------------------------- ---------------------- --------------------------------------------- -------------------------------- ----------------- ------------------------------------------------
  Algeria                            2010                   IV                                            2010                             Yes               [@bib0270]

  Angola                             2012                   IV                                            2012                             No                [@bib0565]

  Benin                              1972                   NA                                            NA                               No                [@bib0175]

  Burkina Faso                       NA                     I                                             1988                             Yes               [@bib0655], [@bib0515]

                                                            II                                            1999                             No                [@bib0095]

  Cameroon                           NA                     IV                                            1997                             Yes               [@bib0095]

  Central African Republic           NA                     IV                                            2004                             Yes               [@bib0095]

  Chad                               1971                   II                                            1993                             No                [@bib0760], [@bib0160], [@bib0565]

  Comoros                            2010                   NA                                            NA                               No                [@bib0345]

  Congo                              NA                     IV                                            2006                             No                [@bib0675]

  Democratic Republic of the Congo   2012                   IV                                            2012                             No                [@bib0565], [@bib0675]

  Egypt                              1987                   IV                                            2009, 2010, 2012                 Yes               [@bib0475], [@bib0095], [@bib0005], [@bib0905]

  Eritrea                            NA                     IV                                            2002, 2003, 2005, 2011           Yes               [@bib0240]

  Ethiopia                           1994                   III                                           1994, 1996                       Yes               [@bib0795], [@bib0515], [@bib0095]

                                                            IV                                            2010                             Yes               [@bib0675], [@bib0685]

  Gabon                              NA                     IV                                            2011                             Yes               [@bib0595]

  Ghana                              NA                     II                                            1976, 1978, 2010                 Yes               [@bib0515], [@bib0095], [@bib0315]

  Guinea                             NA                     I                                             1988, 1991                       Yes               [@bib0515], [@bib0095]

  Guinea Bissau                      NA                     I                                             1989                             Yes               [@bib0515]

  Ivory Coast                        1942                   I                                             1989                             Yes               [@bib0395], [@bib0215]

  Kenya                              2006                   III                                           2006                             Yes               [@bib0950], [@bib0565]

  Libya                              NA                     NA                                            NA                               No                [@bib0565]

  Mali                               NA                     II                                            1999                             Yes               [@bib0515]

  Mauritania                         NA                     II                                            2012                             Yes               [@bib0325]

  Morocco                            2008                   IV                                            2008                             Yes               [@bib0525], [@bib0530], [@bib0670]

  Niger                              NA                     II                                            2012                             No                [@bib0355], [@bib0565]

  Nigeria                            1967                   II                                            1975, 1976, 2010, 2012, 2013     Yes               [@bib0430], [@bib0295], [@bib0215], [@bib0970]

                                                            IV                                            2008, 2009, 2010, 2012, 2013     Yes               [@bib0580], [@bib0970]

  Senegal                            1955                   I                                             1964, 1994                       Yes               [@bib0645], [@bib0515]

                                                            II                                            2010, 2013                       Yes               [@bib0095], [@bib0835]

  Sierra Leone                       2008                   II                                            2009                             Yes               [@bib0660]

  Somalia                            2006                   III                                           NA                               No                [@bib0705], [@bib0565]

  Sudan                              1971                   III                                           1971, 1972, 2000                 Yes               [@bib0035], [@bib0525], [@bib0530], [@bib0095]

                                                            IV                                            2000, 2005, 2008, 2009           Yes               [@bib0095], [@bib0525], [@bib0530]

  Tanzania                           2008                   III                                           2010, 2011, 2013                 Yes               [@bib0095], [@bib0485]

  Togo                               1972                   NA                                            NA                               No                [@bib0145]

  Tunisia                            NA                     IV                                            2012, 2013                       Yes               [@bib0880]

  Uganda                             1995                   III                                           2007                             No                [@bib0915], [@bib0095]

                                                            IV                                            2007, 2008                       Yes               [@bib0585], [@bib0685]

  Western Sahara                     NA                     IV                                            2010                             No                [@bib0565]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA: not available.

Lineages of isolates of *Peste des petits ruminants virus* were named by following the classification of lineages based on partial N gene sequence phylogenetic analysis.

###### 

Lineages of *Peste des petits ruminants virus* circulating in different countries of Asia, based on partial N/F gene sequence analysis.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country                Year of first report   Lineage[a](#tblfn0010){ref-type="table-fn"}   Year of confirmation\                                                          NCBI submission   References
                                                                                              of outbreak through sequencing                                                                   
  ---------------------- ---------------------- --------------------------------------------- ------------------------------------------------------------------------------ ----------------- ------------------------------------------------------------------------
  Afghanistan            1995                   NA                                            NA                                                                             No                [@bib0630]

  Bangladesh             1993                   IV                                            2000, 2008, 2009, 2010, 2011, 2012                                             Yes               [@bib0470], [@bib0780]

  Bhutan                 2010                   IV                                            2010                                                                           Yes               [@bib0095]

  China                  2007                   IV                                            2007, 2008, 2014                                                               Yes               [@bib0955], [@bib0100]

  India                  1987                   IV                                            1994, 1995, 1996, 1998, 1999, 2004, 2002, 2001, 2003, 2005, 2007, 2008, 2012   Yes               [@bib0885], [@bib0695], [@bib0890], [@bib0280], [@bib0480], [@bib0070]

  Iran                   1995                   IV                                            1998,2010,2011,2012                                                            Yes               [@bib0140], [@bib0515]

  Iraq                   1998                   IV                                            2011, 2012, 2013                                                               Yes               [@bib0095]

  Israel                 1993                   IV                                            1993, 1995,1998,                                                               Yes               [@bib0745], [@bib0515]

  Jordan                 1991                   NA                                            NA                                                                             No                [@bib0535]

  Kazakhstan             1997                   NA                                            NA                                                                             No                [@bib0590]

  Kuwait                 1999                   IV                                            1999                                                                           Yes               [@bib0280], [@bib0095]

  Lebanon                2006                   NA                                            NA                                                                             No                [@bib0450]

  Nepal                  1995                   IV                                            1995, 2009                                                                     Yes               [@bib0280], [@bib0095]

  Oman                   1987                   III                                           1983, 1987                                                                     Yes               [@bib0440], [@bib0515], [@bib0095], [@bib0685]

  Qatar                  1987                   III                                           2010                                                                           Yes               [@bib0095]

                                                IV                                            2010                                                                           Yes               [@bib0095]

  Pakistan               1991                   IV                                            1994, 2005, 2006, 2007, 2008, 2009, 2010, 2012,                                Yes               [@bib0040]

  Saudi Arabia           1980                   IV                                            1999, 2004                                                                     Yes               [@bib0050], [@bib0515], [@bib0095]

  Tajikistan             2004                   IV                                            2004                                                                           Yes               [@bib0515]

  Turkey                 1996                   IV                                            1996,2000, 2006,2007,2008,2009,2010,2011                                       Yes               [@bib0030], [@bib0515], [@bib0095]

  United Arab Emirates   1983                   III                                           1986                                                                           Yes               [@bib0375]

                                                IV                                            NA                                                                             No                [@bib0095], [@bib0685]

  Vietnam                2007                   NA                                            NA                                                                             No                [@bib0610]

  Yemen                  2001                   III                                           2001, 2009                                                                     Yes               [@bib0280], [@bib0095]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA: not available.

Lineages of isolates of *Peste des petits ruminants virus* were named by following the classification of lineages based on partial N gene sequence phylogenetic analysis.

###### 

Reported infection of wildlife species by *Peste des petits ruminants virus*.

  Common name                Zoological name                 Diagnostic method                                 Country                              Reference
  -------------------------- ------------------------------- ------------------------------------------------- ------------------------------------ ------------
  Afghan Markhor goat        *Capra falconeri*               Clinical, serological and molecular examination   United Arab Emirates                 [@bib0500]
  African grey duiker        *Sylvicapra grimma*             Serological examination                           Nigeria                              [@bib0715]
  Arabian gazelle            *Gazella gazella*               Clinical, serological and molecular examination   United Arab Emirates                 [@bib0500]
  Arabian mountain gazelle   *Gazella gazella cora*          Clinical, serological and molecular examination   United Arab Emirates                 [@bib0500]
  Arabian oryx               *Oryx leukoryx*                 Serological examination                           Saudi Arabia, United Arab Emirates   [@bib0370]
  Barbary sheep              *Ammotragus lervia*             Clinical, serological and molecular examination   United Arab Emirates                 [@bib0500]
  Bharal                     *Pseudois nayaur*               Clinical, serological and molecular examination   China                                [@bib0110]
  Bubal hartebeests          *Alcelaphus buselaphus*         Serological examination                           Ivory Coast                          [@bib0250]
  Buffalo                    *Syncerus caffer*               Serological examination                           Ivory Coast                          [@bib0250]
  Bushbuck                   *Tragelaphus scriptus Kinne*    Clinical, serological and molecular examination   United Arab Emirates                 [@bib0500]
  Defassa waterbuck          *Kobus defassa*                 Serological examination                           Ivory Coast                          [@bib0250]
  Dorcas gazelle             *Gazella dorcas*                Clinical examination                              United Arab Emirates                 [@bib0375]
  Gemsbok                    *Oryx gazella*                  Clinical examination                              United Arab Emirates                 [@bib0375]
  Impala                     *Aepyceros melampus*            Clinical, serological and molecular examination   United Arab Emirates                 [@bib0500]
  Kob                        *Kobus kob*                     Serological examination                           Ivory Coast                          [@bib0250]
  Laristan sheep             *Ovis gmelini*                  Clinical examination                              United Arab Emirates                 [@bib0375]
  Nubian ibex                *Capra nubiana*                 Clinical examination                              United Arab Emirates                 [@bib0375]
  Persian gazelle            *Gazella subgutturosa*          Serological examination                           Turkey                               [@bib0420]
  Rheem gazelle              *Gazella subguttorosa marica*   Clinical, serological and molecular examination   United Arab Emirates                 [@bib0500]
  Sindh ibex                 *Capra aegagrus blythi*         Clinical and serological examination              Pakistan                             [@bib0015]
  Springbuck                 *Antidorcas marsupialis*        Clinical, serological and molecular examination   United Arab Emirates                 [@bib0500]
  Thompson's gazelle         *Eudorcas thomsonii*            Clinical examination                              Saudi Arabia                         [@bib0010]
  White-tailed deer          *Odocoileus virginianus*        Clinical examination                              United States of America             [@bib0425]
  Wild goat                  *Capra aegagrus*                Clinical and serological examination              Kurdistan ( *sic*)                   [@bib0455]

###### 

Laboratory methods available for the diagnosis of peste des petits ruminants.

  Method                            Objective   Reference                                                                                                   
  --------------------------------- ----------- ----------- ----- ----- ----- ----------------------------------------------------------------------------- ------------------------------------
  Agar gel immunodiffusion          --          --          \+    --    \+                                                                                  [@bib0320]
  Competitive ELISA                 ++          ++          --    +++   +++   c-H ELISA                                                                     [@bib0045], [@bib0840]
                                                                              c-N ELISA                                                                     [@bib0560]
  Counter immuno-electrophoresis    --          --          \+    --    --                                                                                  [@bib0615]
  Immuno-capture ELISA              --          --          +++   --    --                                                                                  [@bib0555]
  PCR                               --          --          +++   --    --    RT-PCR based on F gene                                                        [@bib0365]
                                                                              RT-PCR based on N gene                                                        [@bib0245]
                                                                              Multiplex RT-PCR                                                              [@bib0400], [@bib0845]
                                                                              LAMP                                                                          [@bib0545]
                                                                              Real-time RT-PCR (qRT-PCR)                                                    [@bib0105], [@bib0135], [@bib0520]
  Virus isolation in cell culture   --          --          ++    --    --    Cells-Vero, B95a and the vero expressing dog SLAM, CV1 expressing goat SLAM   [@bib0020]
  Virus neutralisation              +++         +++         --    +++   +++                                                                                 

+++: recommended method, ++: suitable method, +: may be used in some situations, but cost, reliability or other factors severely limits its application, --: not appropriate for the purpose.

###### 

Characteristics of attenuated vaccines against peste des petits ruminants.

  --------------------------------------------------------------------------------------------------------------------------------------------------
  Parametre             Vaccine strain                                                                                    
  --------------------- --------------------------------------- --------------------------------------------------------- --------------------------
  Passage and origin    LK-6, BK-2, Vero-63\                    B95a-10, Vero-59\                                         Vero 75\
                        Nigeria, sheep                          North India, goat                                         South India, sheep

  Complete CPE          3--6 days                               3--6 days                                                 2--3 days, rapid growing

  Safety in pregnancy   Safe                                    Safe                                                      Safe

  Lineage               II                                      IV                                                        IV

  Use                   Extensively used in several countries   Extensively used in India (\>20.000.000 doses annually)   Used in some areas\
                                                                                                                          in India

  Virus sequence        Full genome sequenced                   Full genome sequenced                                     Not available
  --------------------------------------------------------------------------------------------------------------------------------------------------
